xenon xe-127
Small moleculeapprovedImaging agent
Approved
Oct 1, 1982
XENON XE-127, a radioactive gas, was developed at Brookhaven National Laboratory in 1973 for lung ventilation imaging. It appears to be preferable to xenon-133 because of the higher counting rates, lower patient radiation dose, and longer shelf life. However, its production ceased in 1993 due to various reasons. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1980s
- Oct 1, 1982
Avon Products — Earliest FDA Approval
- Oct 1, 1982
Mallinckrodt — NDA Secondary Org
- Oct 1, 1982
Avon Products — NDA Secondary Org
- Oct 1, 1982
Avon Products — NDA Organization
Indications
Mechanism of action
- Unspecified targetOTHER
Diagnostic agent
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedOct 1, 1982
Chemistry & pharmacology
Loading structure…
SMILES
[127Xe]- Mol. weight
- 126.905179581 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Topical
- Availability
- Discontinued
- Imaging
- 127-xenon
Oral
No
Parenteral
No
Topical
Yes
Sources
- NCATSH95KBR1GDB ↗
- ChEMBLCHEMBL1200673 ↗
Also known as
- 127xe
- 127xe
- xe 127
- xenon-127
- xenon (127xe)
- xenon (127xe)
- xenon (127xe) gas
- xenon (127xe) gas
- xenon (127xe) gas
- xenon (127xe) gas
- xenon xe 127
- xenon xe 127
- xenon xe 127
- xenon xe-127
- xenon xe-127
- xenon xe-127
- xenon xe-127
Organizations
Marketing (3)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Avon Products | For profit | NDA2 | Oct 1, 1982 |
| Avon Products | For profit | NDA | Oct 1, 1982 |
| Mallinckrodt | For profit | NDA2 | Oct 1, 1982 |